Takaji Kittaka Jr, MD, has coordinated the integration of 3 hospitals, 2800 employees, and disparate physicians, while helping to create nurse navigator positions and population managers. Uniting all of these specialties in the common goal of achieving greater alignment was the topic of Dr Kittaka's presentation at the National Association of Managed Care Physicians' Spring Managed Care Forum 2014 in Orlando.
Takaji Kittaka Jr, MD, is the chief transformational officer at Adena Health System. Adena sits in a unique position, geographically based in an impoverished section of rural southeastern Ohio that has exceptionally high diabetes rates, approaching 30% in some counties. Dr Kittaka has coordinated the integration of 3 hospitals, 2800 employees, and disparate physicians, while helping to create nurse navigator positions and population managers. Uniting all of these specialties in the common goal of achieving greater alignment was the topic of Dr Kittaka’s presentation at the National Association of Managed Care Physicians’ Spring Managed Care Forum 2014 in Orlando, entitled “Risk Stratification: The Practical Implementation of a Powerful Tool.” Dr. Kittaka went on to describe the many successes of this integration.
Their analysis of patients from the 3 hospitals in the region yielded a risk stratification of approximately 5% in the “high risk” category, with this population accounting for approximately 25% of the total cost of care. Other patients were categorized into either the “rising risk” or “low risk” categories. Most significantly, a graphical analysis with margin on the Y-axis revealed margin erosion if no care management strategy was enacted. An effective care management strategy would result in a positive margin slope, indicative of a financially sustainable business model.
Initially, Dr Kittaka sought something that resembled the software application Turbo Tax. Surprisingly, he said, it was nowhere to be found. So they began to develop a simple, user-friendly, open-box platform. It is an ongoing process that requires continuous interaction with physicians and nurses on the front lines, and it was developed starting with the Charleston Comorbidity Index in an attempt to properly assessing risk.
They had to add diabetes-specific risk stratification along with diabetes care guidelines that would be widely agreed-upon. They would also give consideration to evidence-based guidelines, presenting this as well to individual physicians for consideration. In a pilot program, nurse navigator and population health manager positions were created to identify high risk populations and to educate patients.
Dr Kittaka presented a case study of a patient who benefited from this integration. The individual had normal cholesterol and renal function, but their glycated hemoglobin (HbA1C) was very high (13.1). The 68-year-old woman who worked at Wal-Mart agreed to see a doctor, who asked her how she felt. She responded, “Okay, I guess.” The patient began glucophage treatment, and this dialogue was repeated several times; but her HbA1C levels were not going down. Enter the nurse navigator, who determined that the patient did not have a regular work schedule, sometimes working extremely early mornings in the bakery before getting shifted to later hours. So the nurse navigator, together with the patient, talked to the manager at Wal-Mart. After getting more regular hours and thus a more consistent sleep schedule, the patient was able to get her HbA1C levels to below 7—a stunning achievement. The nurse navigator was able to identify the patient as someone who could benefit from some patient engagement and ultimately, measurable success was realized.
Still today, Dr Kittaka wishes there was a single comprehensive platform, but we’re not quite there yet, he lamented. Nonetheless, the population managers help to sound the alert in identifying patients that are most likely to benefit from greater attention.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More